| Financial Year |
March 31 2023 |
| Monetary Funds |
2,400,336,493.40 |
| Held-for-trading Financial Assets |
67,482,116.90 |
| Notes Receivable |
489,000.00 |
| Accounts Receivable |
839,949,630.41 |
| Advances to Suppliers |
491,967,462.81 |
| Other Receivables |
71,974,023.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
916,839,916.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
254,599,954.56 |
| Total Current Assets |
5,043,738,599.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
189,959,349.64 |
| Investment Properties |
-- |
| Fixed Assetes |
6,403,390,842.96 |
| Under-construction Projects |
1,142,869,268.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,142,977,867.26 |
| R&D expenses |
-- |
| Goodwill |
56,283,077.21 |
| Long-Term Deferred and Prepaid Expenses |
82,902,600.02 |
| Deferred Income Tax Assets |
114,717,656.09 |
| Other Non-Current Assets |
188,250,706.62 |
| Sub-Total of Non-Current Assets |
11,321,261,055.65 |
| Total Assets |
16,364,999,654.68 |
| Short-Term Loans |
1,738,623,666.70 |
| Trading Financial liabilities |
176,053,674.00 |
| Notes Payable |
166,978,542.42 |
| Accounts Payable |
1,707,628,296.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
117,462,519.50 |
| Taxes Payable |
155,156,193.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
275,813,084.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
248,392,269.54 |
| Other Current Liabilities |
67,005,281.72 |
| Sub-Total of Current Liabilities |
6,223,011,155.26 |
| Long-term Loans |
1,504,560,986.28 |
| Bonds Payable |
1,320,000,000.00 |
| Long-Term Accounts Payable |
58,176,440.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
548,839,596.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,551,873,916.55 |
| Total Liabilities |
9,774,885,071.81 |
| Paid-In Capital(Or Share Stock) |
954,658,800.00 |
| Capital Surplus |
435,232,668.76 |
| Surplus Reserve |
349,550,223.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,895,171,954.54 |
| Minority Stockholder's Interest |
988,535,915.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,601,578,667.24 |
| Owner's Equity（Stockholder's Equity） |
6,590,114,582.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,364,999,654.68 |
